When Does Wegovy Start Working — and What Does 'Right Away' Actually Mean?

Does semaglutide do anything the moment it enters your system?

Yes, but not in the way most people expect. From the first injection, semaglutide binds to GLP-1 receptors in the gut and brain, slowing gastric emptying and beginning to influence hunger signalling. You might notice you feel full sooner at meals, or that the strong pull towards snacking feels quieter. Some people describe this within days. Others notice nothing at all at 0.25 mg and wonder whether the pen is working.

Both experiences are normal. The starting dose exists to let your digestive system adjust, nausea and discomfort are common early on, and beginning low reduces them. Think of the first four weeks less as treatment and more as preparation. Your prescriber sets the pace of dose increases; this is not something to rush.

For a fuller picture of the mechanism behind these early changes, the explanation of how Wegovy works covers the GLP-1 pathway in plain detail.

When do people typically notice appetite and weight changes?

Appetite is usually the first thing to shift. Many people find that somewhere between week one and week three, meals feel satisfying with less food, and the background noise of hunger between meals drops. This happens before weight loss becomes visible because the calorie deficit needs time to accumulate.

On the scales, a small initial drop in the first two weeks is common, partly genuine fat loss, partly water and glycogen shifts. Then things often plateau briefly while the body adjusts. This can feel alarming if you were expecting a steady line downward from day one, and if you want to understand whether Wegovy starts working right away, that page walks through what the early weeks typically look like. It is not a sign the medicine has stopped working.

By weeks four to eight, as the dose increases, the appetite effect typically deepens and weight loss becomes more consistent. The NHS patient information for semaglutide describes this titration process and what to monitor during each phase.

How long does it take to reach the results seen in clinical trials?

The headline figures from the STEP 1 trial (approximately 15% average body-weight reduction) were recorded at 68 weeks. That is well over a year of treatment at the 2.4 mg maintenance dose, alongside reduced-calorie eating and increased activity. Progress was not linear: the steepest losses tended to fall between months three and twelve, with a gradual slowing thereafter as the body reached a new equilibrium.

This is worth holding in mind when the first month feels slow. A 1–2 kg loss in week four is not a failure; it is the early segment of a much longer curve. Real-world outcomes vary, factors like starting weight, diet, activity level and how well the dose is tolerated all play a part. Clinical trial figures reflect averages across thousands of participants under controlled conditions, and they are the best evidence available, but your own trajectory will be your own.

If you are weighing up Wegovy against other licensed options, the semaglutide overview sets out what the evidence says across different populations. Cost context for private treatment is on the Wegovy price comparison page.

What slows early progress, and what genuinely helps?

A few things consistently blunt Wegovy's early effect. Alcohol adds calories quietly and can worsen nausea. Very high-fat meals amplify GI side effects, making people eat less, but not comfortably. Inadequate protein intake during rapid weight loss accelerates muscle loss alongside fat. And poor sleep raises hunger hormones that work against the medicine's appetite suppression.

None of this needs to be perfect. The medicine helps; lifestyle changes compound its effect. Keeping the pen in the fridge door as a visible weekly prompt, rather than tucked away, helps some people stay consistent with the injection routine. Simple, but consistency matters more than optimisation in the first month.

If you are still uncertain whether Wegovy fits your situation, the assessment of who Wegovy suits addresses eligibility and the clinical factors a prescriber considers. The weight-loss treatment overview covers all licensed options available through nume. When you are ready to take the next step, our prescribers review every consultation personally, speak to our prescribers to get started with a free clinical assessment.